substance p has been researched along with Cerebral Infarction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, A; Hagiwara, H; Katayama, Y; Katsura, K; Nishiyama, Y; Okubo, S; Ueda, M | 1 |
| Cuello, AC; Hughes, JT; Pioro, EP | 1 |
| Becker, LE; Mito, T; Nishimura, A; Takashima, S | 1 |
| Arai, T; Fujiwara, H; Kashiki, Y; Takaya, T; Toshima, S; Yasuda, Y; Yoshimi, N | 1 |
| Cramer, H; Kuntzmann, F; Rissler, K; Schaudt, D; Strubel, D; Warter, JM | 1 |
1 trial(s) available for substance p and Cerebral Infarction
| Article | Year |
|---|---|
Administration of cilostazol, an antiplatelet, to patients with acute-stage cerebral infarction and its effects on plasma substance P level and latent time of swallowing reflex.
Topics: Acute Disease; Aged; Aged, 80 and over; Cerebral Infarction; Cilostazol; Deglutition; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Reflex; Substance P; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
4 other study(ies) available for substance p and Cerebral Infarction
| Article | Year |
|---|---|
Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
Topics: Adult; Aged; Cerebral Infarction; Corpus Striatum; Enkephalins; Globus Pallidus; Humans; Immunoenzyme Techniques; Neural Pathways; Substance P; Substantia Nigra | 1984 |
Aberrant distribution of tyrosine hydroxylase and substance P in infants with brain-stem infarction.
Topics: Brain Stem; Cerebellar Diseases; Cerebral Infarction; Humans; Immunohistochemistry; Infant; Infant, Newborn; Respiratory Insufficiency; Substance P; Tyrosine 3-Monooxygenase | 1994 |
ACE inhibitors and symptomless dysphagia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Cerebral Hemorrhage; Cerebral Infarction; Cough; Deglutition Disorders; Female; Humans; Hypertension; Male; Substance P | 1998 |
Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Topics: Aged; Alzheimer Disease; Cerebral Infarction; Female; Humans; Hydrocephalus; Male; Middle Aged; Radioimmunoassay; Somatostatin; Substance P; Syndrome | 1985 |